IMBRUVICA® (ibrutinib)

Bruton's Tyrosine Kinase (BTK) Inhibitor

Potential of IMBRUVICA®

Pharmacyclics is committed to fully exploring the potential of IMBRUVICA® as a new therapy for additional diseases with great unmet medical need. Over the next 5+ years, IMBRUVICA’s unique mechanism of action is being studied in up to 10 disease areas.